Pinnacle Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History

Pinnacle Advisory Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,165	Closed	-$236K	–	166
2019 Q2	$236K	Buy	2,165 +135	+7%	+$14.4K	0.02%	155
2019 Q1	$227K	Buy	+2,030	New	+$223K	0.02%	153
2018 Q2	–	Sell	-4,300	Closed	-$459K	–	164
2018 Q1	$459K	Sell	4,300 -6,680	-61%	-$740K	0.03%	124
2017 Q4	$1.17M	Buy	10,980 +1,209	+12%	+$129K	0.07%	73
2017 Q3	$1.09M	Buy	9,771 +240	+3%	+$25.7K	0.07%	69
2017 Q2	$985K	Buy	9,531 +195	+2%	+$19.2K	0.06%	75
2017 Q1	$913K	Buy	9,336 +1,326	+17%	+$127K	0.06%	75
2016 Q4	$709K	Buy	8,010 +750	+10%	+$68.3K	0.05%	85
2016 Q3	$653K	Buy	+7,260	New	+$691K	0.05%	58

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Pinnacle Advisory Group's IBB Position: Q3 2019 in Review

Pinnacle Advisory Group sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 2,165 shares — an estimated $236K sold.

Pinnacle Advisory Group first reported a position in IBB in Q3 2016 and held it in 9 quarters. The position peaked at $1.17M in Q4 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Pinnacle Advisory Group reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Pinnacle Advisory Group sold 2,165 iShares Biotechnology ETF shares in Q3 2019, an estimated $236K.
Pinnacle Advisory Group first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 9 quarters.
Pinnacle Advisory Group's iShares Biotechnology ETF position peaked at $1.17M in Q4 2017.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Pinnacle Advisory Group's 13F filing for Q3 2019, filed 17 Oct 2019.